Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-089780
Filing Date
2024-08-14
Accepted
2024-08-14 18:52:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2421639d1_sc13da.htm SC 13D/A 42023
  Complete submission text file 0001104659-24-089780.txt   43488
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Subject) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91017 | Film No.: 241210088
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Shendelman Shoshana (Filed by) CIK: 0001775490 (see all company filings)

Type: SC 13D/A